Curi Bio is a biotechnology company that specializes in developing advanced tools and technologies for drug discovery and development. The company focuses on creating innovative solutions that enhance the understanding of human biology and disease mechanisms. Curi Bio's offerings include platforms for human cell-based assays and organ-on-a-chip technologies, aimed at improving the efficiency and effectiveness of pharmaceutical research. Their products are designed to support researchers in generating more predictive preclinical data, ultimately accelerating the drug development process.